New Message!

You have secured a spot at

Registration Not Accepted

You have been checked in to

Explore our upcoming events and secure your tickets now!

You’ve been marked as not going

Message from the host

Order complete

You are pending approval

Payment Successful!

Thank you for joining our event!

Event Starting Soon

Returning to scan in {seconds} seconds...

Ticket Invalid

Point your ticket QR code at the scanner

Scan Your Ticket

Invalid Kiosk Code

Check-In Successful!

Already Checked In

Access Your Tickets

You’re on the waitlist for {{event_title}}

Registration approved for {{event_title}}

Please fill in the RSVP confirmation name and email fields.

Confirm your email for faster checkout next time

name

description

location

online_event

9e70c28f-6b25-4edb-ae0a-815d5e56d5b4

Upcoming Events

Earn Up to 2 hours of CME!
Zoom Meeting Platform
Pre-Registration is required.
Registration Fee: $25.00

The goal of this activity is to enable learners to better understand the recent data on bruton tyrosine kinase (BTK) inhibitors and how they may change practice in managing patients with B-cell malignancies (eg, chronic lymphocytic leukemia [CLL]/small lymphocytic leukemia [SLL] and mantle cell lymphoma [MCL]).

null

Incorporating BTK Inhibitors Therapy into Clinical Practice for the Management of B Cell Malignancies


e1dde512-aee7-4409-8d85-732939676884

Registration

Incorporating BTK Inhibitors Therapy into Clinical Practice for the Management of B-Cell Malignancies

Join our wait list to be notified when tickets become available.